bromethenmadinone acetate bromethenmadinone acetate bromethenmadinone acetate (bmma, also known as bromsuperlutin) is a progestin medication which was developed in czechoslovakia and was described in 1970 but was never marketed. analogues of bmma include chlormethenmadinone acetate, melengestrol acetate, and methenmadinone acetate. bromethenmadinone acetateclinical dataother namesbmma; bromsuperlutin; 6-bromo-16-methylene-17α-hydroxy-δ6-progesterone acetate; 6-bromo-16-methylene-17α-acetoxypregna-4,6-diene-3,20-dionedrug classprogestogen; progestin; progestogen esteridentifiers iupac name phenanthren-17-yl] acetate cas number24431-75-2pubchem cid90679394chemspider34249907chemblchembl3276152chemical and physical dataformulac24h29bro4molar mass461.396 g·mol−13d model (jsmol)interactive image smiles cc(=o)1(c(=c)c21(cc32c=c(c4=cc(=o)cc34c)br)c)oc(=o)c inchi inchi=1s/c24h29bro4/c1-13-10-19-17-12-21(25)20-11-16(28)6-8-22(20,4)18(17)7-9-23(19,5)24(13,14(2)26)29-15(3)27/h11-12,17-19h,1,6-10h2,2-5h3/t17-,18+,19+,22-,23+,24+/m1/s1key:giudlkyatchbdt-usynndfzsa-n